Published in Clin Sci (Lond) on August 01, 1995
Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol (2008) 0.93
Increased release of the soluble form of the adhesion molecules L-selectin and ICAM-1 but not E-selectin during attacks of angina pectoris. Heart Vessels (1998) 0.78
Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatment. Neth Heart J (2001) 0.75
[Polymorphonuclear neutrophils in myocardial ischemia and reperfusion injury. Influence of coronary intervention?]. Z Kardiol (2004) 0.75
Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest (1980) 2.41
Adrenergic hypersensitivity after beta-blocker withdrawal. Br Heart J (1981) 1.87
Nifedipine and left ventricular function in beta-blocked patients. Br Heart J (1981) 1.85
Acute haemodynamic effects of felodipine during beta blockade in patients with coronary artery disease. Br Heart J (1984) 1.74
Hypertrophy causes delayed conduction in human and guinea pig myocardium: accentuation during ischaemic perfusion. Cardiovasc Res (1994) 1.63
Reduced anisotropy of action potential conduction in left ventricular hypertrophy. J Cardiovasc Electrophysiol (2001) 1.43
Biopterin derivatives in human body fluids and tissues. J Clin Pathol (1976) 1.41
Arrhythmias and cellular electrophysiological changes during myocardial "ischaemia" and reperfusion. Cardiovasc Res (1983) 1.26
Developing hospital-based domestic violence programs, protocols, policies, and procedures. AWHONNS Clin Issues Perinat Womens Health Nurs (1993) 1.22
Changes in cell-to-cell electrical coupling associated with left ventricular hypertrophy. Circ Res (1997) 1.17
Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle. J Appl Physiol (1985) (2000) 1.16
The carotid intima-media thickness as a marker of the presence of severe symptomatic coronary artery disease. Eur Heart J (1994) 1.12
The effects of diadenosine polyphosphates on the cardiovascular system. Cardiovasc Res (1999) 1.02
Coronary microangiography in the guinea pig, rabbit and ferret. Int J Cardiol (1984) 0.97
Lichen myxoedematosus with associated cardiac abnormalities. Br J Dermatol (2001) 0.96
Conduction velocity and gap junction resistance in hypertrophied, hypoxic guinea-pig left ventricular myocardium. Exp Physiol (1998) 0.95
Arrhythmogenic and electrophysiological effects of alpha adrenoceptor stimulation during myocardial ischaemia and reperfusion. J Mol Cell Cardiol (1987) 0.94
Platelet counts and aggregates in coronary artery disease. Eur Heart J (1982) 0.91
Haemodynamics and plasma concentrations following sublingual GTN and intravenous, or inhaled, isosorbide dinitrate. Br J Clin Pharmacol (1984) 0.91
Neutrophil interactions with endothelium and platelets: possible role in the development of cardiovascular injury. Eur Heart J (1995) 0.90
Electrophysiological and antiarrhythmic effects of UK 52,046-27 during ischaemia and reperfusion in the guinea-pig heart. Br J Pharmacol (1989) 0.90
Antiarrhythmic and electrophysiological effects of alpha adrenoceptor blockade during myocardial ischaemia and reperfusion in isolated guinea-pig heart. J Mol Cell Cardiol (1985) 0.90
Reforming research in the NHS. BMJ (2005) 0.90
Regression of left ventricular hypertrophy in hypertensive patients treated with indapamide SR 1.5 mg versus enalapril 20 mg: the LIVE study. J Hypertens (2000) 0.90
Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia. Cardiovasc Res (1995) 0.87
Expression of a suppressive p15E-related epitope in colorectal and gastric cancer. Br J Cancer (1993) 0.87
Antiarrhythmic action of lignocaine in early myocardial infarction. Plasma levels after combined intramuscular and intravenous administration. Lancet (1977) 0.86
Capillary filtration is reduced in lungs adapted to chronic heart failure: morphological and haemodynamic correlates. Cardiovasc Res (2001) 0.86
Cardiac alpha- and beta-adrenoceptor sensitivity and binding characteristics after chronic reserpine pretreatment. Naunyn Schmiedebergs Arch Pharmacol (1987) 0.86
Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris. Br J Clin Pharmacol (1987) 0.86
Effects of myocardial catecholamine depletion on cellular electrophysiology and arrhythmias during ischaemia and reperfusion. Cardiovasc Res (1984) 0.86
Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects. Cardiovasc Res (1994) 0.86
A microcomputer system for real-time analysis of cardiac action potentials. J Med Eng Technol (1983) 0.85
Endogenous and exogenous coronary vasodilatation are attenuated in cardiac hypertrophy: a morphological defect? J Mol Cell Cardiol (2000) 0.85
Vascular versus myocardial selectivity of calcium antagonists. J Cardiovasc Pharmacol (1987) 0.85
Contribution of nitric oxide and prostanoids to the cardiac electrophysiological and coronary vasomotor effects of diadenosine polyphosphates. J Pharmacol Exp Ther (2001) 0.84
Electrophysiological effects of alpha-adrenoceptor stimulation in normal and ischemic myocardium. J Cardiovasc Pharmacol (1985) 0.83
Investigation of mechanisms that mediate reactive hyperaemia in guinea-pig hearts: role of K(ATP) channels, adenosine, nitric oxide and prostaglandins. Br J Pharmacol (2001) 0.83
Acute haemodynamic effects of cromakalim in patients with angina pectoris. Br J Clin Pharmacol (1990) 0.83
Electrophysiological and arrhythmogenic effects of platelet activating factor during normal perfusion, myocardial ischaemia and reperfusion in the guinea-pig. Br J Pharmacol (1990) 0.83
Axillary hyperhidrosis. Its quantification and surgical treatment. Br J Dermatol (1974) 0.82
Qualitative and quantitative observations on ultrastructural changes during postnatal development in the cat myocardium. J Mol Cell Cardiol (1979) 0.82
Swainsonine, a glycosylation inhibitor, enhances both lymphocyte efficacy and tumour susceptibility in LAK and NK cytotoxicity. Immunopharmacology (1994) 0.81
Modulation of neutrophil activity by nitric oxide during acute myocardial ischaemia and reperfusion. Basic Res Cardiol (1995) 0.81
Postnatal ultrastructural changes in the cat myocardium: a morphometric study. Cardiovasc Res (1977) 0.81
Emergency nursing interventions with battered women. J Emerg Nurs (1989) 0.81
Calculated and actual changes in beta-adrenoceptor number associated with increases in rat and guinea-pig cardiac sensitivity. J Pharm Pharmacol (1986) 0.81
Failure of thromboxane synthetase inhibition to improve exercise tolerance in patients with stable angina pectoris. Int J Cardiol (1984) 0.81
Contribution of platelets and platelet-activating factor (PAF) to the arrhythmogenic, haemodynamic and necrotic effects of acute myocardial ischaemia. Eur Heart J (1991) 0.80
Comparison of coronary vasodilator reserve in elite rowing athletes versus hypertrophic cardiomyopathy. Am J Cardiol (1997) 0.80
Generalized seizures as the presentation of flecainide toxicity. Eur Heart J (1989) 0.80
Coronary and peripheral arterial responses to ergometrine in patients susceptible to coronary and oesophageal spasm. Br Heart J (1981) 0.80
Alpha adrenoceptors and arrhythmias. J Mol Cell Cardiol (1986) 0.79
Effects of sotalol on arrhythmias and electrophysiology during myocardial ischaemia and reperfusion. Cardiovasc Res (1984) 0.79
Investigation of the effects of physiological and vasodilation-induced autonomic activation on the QTc Interval in healthy male subjects. Br J Clin Pharmacol (2005) 0.79
Effects of a moderate glycemic meal on exercise duration and substrate utilization. Med Sci Sports Exerc (2001) 0.79
Soluble adhesion molecules in reperfusion during coronary bypass grafting. Eur J Cardiothorac Surg (1998) 0.79
Increased release of the soluble form of the adhesion molecules L-selectin and ICAM-1 but not E-selectin during attacks of angina pectoris. Heart Vessels (1998) 0.78
Electrophysiological disturbances associated with acute myocardial infarction. Eur Heart J (1986) 0.78
Abnormalities of the coronary circulation associated with left ventricular hypertrophy. Clin Sci (Lond) (1991) 0.78
Cardiac post-junctional alpha 1- and beta-adrenoceptors: effects of chronic chemical sympathectomy with 6-hydroxydopamine. J Recept Res (1987) 0.78
Investigation of impaired coronary vasodilator reserve in the guinea pig heart with pressure induced hypertrophy. Eur Heart J (1992) 0.78
Effects of the PAF antagonists BN50726 and BN50739 on arrhythmogenesis and extent of necrosis during myocardial ischaemia/reperfusion in rabbits. Br J Pharmacol (1992) 0.78
Arrhythmias, haemodynamic changes and extent of myocardial damage during coronary ligation in rabbits anaesthetized with halothane, alpha chloralose or pentobarbitone. Int J Cardiol (1991) 0.78
The release of soluble adhesion molecules ICAM-1 and E-selectin after acute myocardial infarction and following coronary angioplasty. Int J Cardiol (1997) 0.78
Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group. Br Heart J (1995) 0.78
Porphyria cutanea tarda. Br J Clin Pract (1972) 0.78
Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors. Br J Cancer (1993) 0.78
Arrhythmias and alpha 1-adrenoceptor binding characteristics of the guinea-pig perfused heart during ischaemia and reperfusion. J Mol Cell Cardiol (1990) 0.78
Cardiac postjunctional supersensitivity to beta-agonists after chronic chemical sympathectomy with 6-hydroxydopamine. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.78
The treatment of heart failure--what next? Br J Clin Pharmacol (1993) 0.78
Nonlinearity of human arterial pulse wave transmission. J Biomech Eng (1992) 0.77
Cardiac hypertrophy impairs recovery from ischaemia because there is a reduced reactive hyperaemic response. Cardiovasc Res (1995) 0.77
Premature ventricular complexes: therapeutic dilemmas and decisions. Adv Cardiol (1980) 0.77
Age-related differences in the pancreatic beta-cell response to hyperglycemia after eccentric exercise. Am J Physiol (1998) 0.77
Assessment of myocardial contractility in man. Cardiovasc Res (1987) 0.77
Cardiac electrophysiological effects of platelet-derived substances. Exp Physiol (1999) 0.77
Acute haemodynamic effects of felodipine in patients with coronary artery disease. Drugs (1985) 0.77
Vascular selectivity of felodipine: clinical experience. J Cardiovasc Pharmacol (1990) 0.76
Comparison of transforming growth factor beta and a human tumour-derived suppressor factor. Cancer Immunol Immunother (1991) 0.76
Postnatal developmental changes in the electrophysiological properties of cat right ventricular papillary muscles. Cardiovasc Res (1980) 0.76
Microangiographic investigation of the effects of radiographic contrast media and hyperkalaemia on coronary artery calibre in the rabbit. Q J Exp Physiol (1989) 0.76
Investigation of distal aortic compliance and vasodilator responsiveness in heart failure due to proximal aortic stenosis in the guinea pig. Clin Sci (Lond) (1999) 0.76
Intracellular pH and H+ buffering capacity in guinea-pigs with left ventricular hypertrophy induced by constriction of the thoracic aorta. Exp Physiol (1997) 0.76
The pathophysiological role of platelets during myocardial ischaemia. Cardiovasc Res (1994) 0.76
Coronary vasomotor and cardiac electrophysiologic effects of diadenosine polyphosphates and nonhydrolyzable analogs in the guinea pig. J Cardiovasc Pharmacol (2001) 0.76
Infantile digital fibromatosis. Proc R Soc Med (1974) 0.75
Acute effects of acebutolol on cardiovascular function in man. Br J Clin Pharmacol (1981) 0.75
Reperfusion arrhythmias. Cardiovasc Res (1993) 0.75
Effects of cicletanine on haemodynamics, arrhythmias and extent of necrosis during coronary ligation in rabbits. Br J Pharmacol (1992) 0.75
Plasma mediated neutrophil stimulation during coronary angioplasty: autocrine effect of platelet activating factor. Br Heart J (1995) 0.75
Acute and chronic effects of flosequinan on resting and exercise haemodynamics in congestive heart failure. Br J Clin Pharmacol (1993) 0.75